Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Research & Development: 2015-2024

Historic Research & Development for Kura Oncology (KURA) over the last 10 years, with Dec 2024 value amounting to $170.0 million.

  • Kura Oncology's Research & Development rose 62.83% to $67.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.9 million, marking a year-over-year change of. This contributed to the annual value of $170.0 million for FY2024, which is 47.50% up from last year.
  • According to the latest figures from FY2024, Kura Oncology's Research & Development is $170.0 million, which was up 47.50% from $115.2 million recorded in FY2023.
  • In the past 5 years, Kura Oncology's Research & Development registered a high of $170.0 million during FY2024, and its lowest value of $60.4 million during FY2020.
  • In the last 3 years, Kura Oncology's Research & Development had a median value of $115.2 million in 2023 and averaged $126.0 million.
  • Data for Kura Oncology's Research & Development shows a peak YoY skyrocketed of 47.50% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Kura Oncology's Research & Development stood at $60.4 million in 2020, then skyrocketed by 40.27% to $84.7 million in 2021, then rose by 9.55% to $92.8 million in 2022, then rose by 24.16% to $115.2 million in 2023, then surged by 47.50% to $170.0 million in 2024.